ABIOMED/ US0036541003 /
| 6/24/2022 9:59:54 PM | Chg. +6.70 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 255.53USD | +2.69% | 21,231 Turnover: 5.35 mill. |
-Bid Size: - | -Ask Size: - | 11.63 bill.USD | 0.00% | 51.06 |
Assets
|
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 87.8000 | 117.2000 | 145 | 164.9000 | 197.1000 | ||||||
| Intangible Assets | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | - | - | - | - | - | ||||||
| Inventories | 34.9000 | 50.2000 | 80.9000 | 90.1000 | 81.1000 | ||||||
| Accounts Receivable | 54.1000 | 70 | 90.8000 | 84.7000 | 97.2000 | ||||||
| Cash and Cash Equivalents | 39 | 43 | 121 | 192.3000 | 232.7000 | ||||||
| Current Assets | 327 | 494.3000 | 677.2000 | 635.9000 | 788 | ||||||
| Total Assets | 550.4000 | 786.4000 | 1,054.3000 | 1,216.5000 | 1,494.4000 | ||||||
Liabilities
|
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 20.6000 | 23.6000 | 32.2000 | 32.8000 | 34.8000 | ||||||
| Long-term debt | - | - | - | - | - | ||||||
| Liabilities to Banks | - | - | - | - | - | ||||||
| Provisions | 16.3000 | .9000 | .8000 | .8000 | .8000 | ||||||
| Liabilities | 98.3000 | 96.9000 | 117.5000 | 151 | 164.7000 | ||||||
| Share Capital | - | - | - | - | - | ||||||
| Total Equity | 452.1000 | 689.5000 | 936.9000 | 1,065.5000 | 1,329.7000 | ||||||
| Minority Interests | - | - | - | - | - | ||||||
| Total liabilities equity | 550.4000 | 786.4000 | 1,054.3000 | 1,216.5000 | 1,494.4000 | ||||||
Income Statement
|
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 445.3000 | 593.7000 | 769.4000 | 840.9000 | 847.5000 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | 90.1000 | 157.1000 | 224.8000 | 249.2000 | 229.6000 | ||||||
| Interest Income | - | - | - | - | - | ||||||
| Income Before Taxes | 91.3000 | 160.4000 | 263.4000 | 256.8000 | 288.2000 | ||||||
| Income Taxes | 39.2000 | 48.3000 | 4.3000 | 53.8000 | 62.7000 | ||||||
| Minority Interests Profit | - | - | - | - | - | ||||||
| Net Income | 52.1000 | 112.2000 | 259 | 203 | 225.5000 | ||||||
Per Share
Cash Flow
|
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 115.1000 | 192.5000 | 252.2000 | 314.9000 | 274.6000 | ||||||
| Cash Flow from Investing Activities | -126.3000 | -180.8000 | -116.5000 | -125.5000 | -223.3000 | ||||||
| Cash Flow from Financing | 3.9000 | -9.1000 | -55.8000 | -117.7000 | -8.1000 | ||||||
| Decrease / Increase in Cash | -1.8000 | 1.3000 | -1.9000 | -.4000 | -2.8000 | ||||||
| Employees | 908 | 1,143 | 1,371 | 1,536 | 1,725 | ||||||